Insulet (PODD) Receivables - Other (2018 - 2023)

Insulet has reported Receivables - Other for 6 years, with the latest figure at $57.6 million in Q1 2023.

• For the quarter ending Q1 2023, Receivables - Other rose 60.89% year-over-year to $57.6 million; the trailing twelve-month figure through Mar 2023 stood at $57.6 million (up 60.89% YoY), and the FY2022 full-year result was $64.7 million, up 150.78% from the prior year.
• Receivables - Other for Q1 2023 stood at $57.6 million, down from $64.7 million in the prior quarter.
• The five-year high for Receivables - Other was $64.7 million in Q4 2022, with the low at $9.5 million in Q1 2019.
• Historically, Receivables - Other has averaged $27.0 million across 5 years, with a median of $17.3 million in 2021.
• Annual changes were most pronounced in 2021 — Receivables - Other decreased 19.28% — and 2022, when it jumped 200.0%.
• Insulet's Receivables - Other stood at $13.5 million in 2019, then dropped by 14.07% to $11.6 million in 2020, then surged by 122.41% to $25.8 million in 2021, then surged by 150.78% to $64.7 million in 2022, then decreased by 10.97% to $57.6 million in 2023.
• The last three Receivables - Other figures came in at $57.6 million (Q1 2023), $64.7 million (Q4 2022), and $48.3 million (Q3 2022), per Business Quant data.